Company profile
Miltenyi Biomedicine
Developing personalized cell and gene therapies
- Industry
- Pharmaceutical Manufacturing
- Employees
- 191
- Headquarters
- Bergisch Gladbach, North Rhine-Westphalia
- Founded
- 2019
- LinkedIn followers
- 8,779
- Office locations
- 2
Miltenyi Biomedicine company summary
Miltenyi Biomedicine is a company in the Pharmaceutical Manufacturing industry, headquartered in Bergisch Gladbach, North Rhine-Westphalia, founded in 2019. On LinkedIn the company has around 191 employees and 8,779 followers. The company lists 2 office locations. Its listed specialties include Clinical Applications, Clinical Development, Clinical Trials, CAR-T cells, Gene Therapy.
What technology does Miltenyi Biomedicine use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Miltenyi Biomedicine
Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bring cancer treatments and regenerative therapies to patients with unmet medical needs worldwide. We work in partnership with physicians and other healthcare providers to expand access to new therapies. Our clinical research program includes: CAR T, CAR NK, our proprietary Adapter CAR™ and induced pluripotent stem cells (iPSC) technologies. For more information, please visit our website at www.miltenyibiomedicine.com.
Specialties
Where is Miltenyi Biomedicine located?
Miltenyi Biomedicine lists 2 office locations.
Compare companies similar to Miltenyi Biomedicine
More companies in Pharmaceutical Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Miltenyi Biomedicine miltenyibiomedicine.com | Pharmaceutical Manufacturing | 191 | 2019 | Bergisch Gladbach, North Rhine-Westphalia |
 Anacor Pharmaceuticals pfizer.com | Pharmaceutical Manufacturing | 108,102 | - | New York, New York |
 Sanofi sanofi.com | Pharmaceutical Manufacturing | 93,352 | - | Paris, France, FR |
 GSK gsk.com | Pharmaceutical Manufacturing | 92,179 | - | London, England |
 Novartis España novartis.com | Pharmaceutical Manufacturing | 85,373 | - | Basel, Baselstadt |
 AstraZeneca astrazeneca.com | Pharmaceutical Manufacturing | 80,667 | - | Cambridge, Cambridgeshire, GB |
 Eli Lilly and Company lilly.com | Pharmaceutical Manufacturing | 57,202 | - | Indianapolis, Indiana |
 Merck merck.us | Pharmaceutical Manufacturing | 44,794 | - | Rahway, New Jersey |
 SUN PHARMA sunpharma.com | Pharmaceutical Manufacturing | 47,764 | 1983 | Mumbai, Maharastra |
 Boehringer Ingelheim boehringer-ingelheim.com | Pharmaceutical Manufacturing | 47,150 | - | Ingelheim am Rhein, Rhineland-Palatinate |
 Cipla cipla.com | Pharmaceutical Manufacturing | 51,911 | - | Mumbai, Maharashtra |
Frequently asked questions about Miltenyi Biomedicine
What does Miltenyi Biomedicine do?
Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bring cancer treatments and regenerative therapies to patients with unmet medical needs worldwide. We work in partnership with physicians and other healthcare providers to expand access to new therapies. Our clinical research program includes: CAR T, CAR NK, our proprietary Adapter CAR™ and induced pluripotent stem cells (iPSC) technologies. For more information, please visit our website at www.miltenyibiomedicine.com.
How many employees does Miltenyi Biomedicine have?
Miltenyi Biomedicine has around 191 employees on LinkedIn.
Where is Miltenyi Biomedicine headquartered?
Miltenyi Biomedicine is headquartered in Bergisch Gladbach, North Rhine-Westphalia.
Where does Miltenyi Biomedicine have offices?
Miltenyi Biomedicine lists 2 office locations, including Bergisch Gladbach, North Rhine-Westphalia, DE; Somerville, Massachusetts, US.
When was Miltenyi Biomedicine founded?
Miltenyi Biomedicine was founded in 2019.
Build a lead list from companies like Miltenyi Biomedicine
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.